1 |
Diaconu S, Predescu A, Moldoveanu A, et al. Helicobacter pylori infection: old and new[J]. J Med Life, 2017,10(2):112-117.
|
2 |
Muhammad JS, Sugiyama T, Zaidi SF. Gastric pathophysiological ins and outs of helicobacter pylori: a review[J]. J Pak Med Assoc, 2013,63(12):1528-1533.
|
3 |
Formichella L, Romberg L, Meyer H, et al. Validation of a novel immunoline assay for patent stratification according to virulence of the infection Helicobacter pylori strain and eradication satus[J]. J Immunol Res, 2017:8394593.
|
4 |
Hage N, Howard T, Phillips C, et al. Structural basis of Lewis(b) antigen binding by the Helicobacter pylori adhesion BabA[J]. Sci Adv, 2015,1(7):e1500315.
|
5 |
Yang X, Li H, Cheng T, et al. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori[J]. Metallomics, 2014,6(9):1731-1736.
|
6 |
Weeks DL, Eskandari S, Scott DR, et al. A H+ -gated urea channel: the link between Helicobacter pylori urease and gastric colonization[J]. Science, 2000,287(5452):482-485.
|
7 |
Yang X, Li H, Lai TP, et al. UreE-UreG complex facilititates nickel transfer and preactivates GTPase of UreG in Helicobacter pylori[J]. J Biol Chem, 2015,290(20):12474-12485.
|
8 |
Miller EF, Maier RJ. Ammonium metabolism enzymes aid Helicobacter pylori acid resistance[J]. J Bacteriol, 2014,196(17):3074-3081.
|
9 |
Tsiksa D, Hanff E, Brunner G. Helicobacter pylori, its urease and Carbonic anhydrases, and Macrophage Nitric Oxide Synthase[J]. Trend Microbiol, 2017,25(8):601-602.
|
10 |
Khatoon J, Prasad KN, Prakash Rai R. Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer[J]. Br J Biomed Sci, 2017,2:1-6.
|
11 |
Siregar G, Sari D, Sungkar T. Serum VEGF levels in Helicobacter pylori cagA and vacA genes[J]. Open Access Maced J Med Sci, 2017,5(2):137-141.
|
12 |
王猛,周伟,张富花,等. 河西走廊地区幽门螺杆菌vacA i区分型及疾病相关性探讨[J]. 中国病原生物学, 2013,8(6):485-488.
|
13 |
Almeida N, Donato MM, Romaozinho JM, et al. Correlation of Helicobacter pylori genotypes with gastric histopathology in the central region of a South-European country[J]. Dig Dis Sci, 2015,61(1):74-85.
|
14 |
Abdi E, Latifi-Navid S, Yazdanbod A, et al. Helicobacter pylori babA2 positivity risk of gastric cancer in Ardabil, a very high-risk area in Iran[J]. Asian Pac J Cancer Prev, 2016,17(2):733-738.
|
15 |
Gu H. Role of Flagella in the pathogensis of Helicobacter pylori[J]. Curr Microbiol, 2017,74(7):863-869.
|
16 |
Howitt MR, Lee JY, Lertsethtakarn P, et al. ChePep controls Helicobacter pylori infection of the gastric glands and chemotaxis in the Epsilonproteobacteria[J]. MBio, 2011,2(4),pii: e00098-11.
|
17 |
Kao CY, Sheu BS, Sheu SM, et al. Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori[J]. Helicobacter, 2012,17(6):411-416.
|
18 |
Khalifeh Gholi M, Kalali B, Formichella L, et al. Helicobacter pylori FliD protein is a highly sensitive and specific marker for serologic diagnosis of H. pylori infection[J]. Int J Med Microbiol, 2013,303(8):618-623.
|
19 |
Lertsethtakarn P, Ottemann KM, Hendrixson DR. Motility and chemotaxis in Campylobacter and Helicobacter[J]. Annu Rev Microbiol, 2011,65:389-410.
|
20 |
Tian W, Jia Y, Yuan K, et al. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer[J]. Helicobacter, 2014,19(7):9-16.
|
21 |
Huang X, Deng Z, Zhang Q, et al. Relationship between the iceA gene of Helicobacter oylori and clinical outcomes[J]. Ther Clin Risk Manag, 2016,12:1085-1092.
|
22 |
王菡,杨江民. 玉树地区居民幽门螺杆菌感染状况调查[J]. 检验医学与临床, 2013,6(10):731-732.
|
23 |
李书群,李晓勤,王梦远. 维、汉、哈族酒依赖患者幽门螺杆菌感染的影响因素研究[J]. 检验医学与临床, 2016,17(13):2486-2489.
|
24 |
Santiago P, Moreno Y, Ferrus MA. Identification of viable Helicobacter pylori in drinking water supplies by cultural and molecular techniques[J]. Helicobacter, 2015,20(4):252-259.
|
25 |
Fedichkina TP, Solenova LG, Zykova IE. On the rating of Helicobacter pylori in drinking water[J]. Gig Sanit, 2014,93(6):42-46.
|
26 |
Bahrami AR, Rahimi E, Ghasemian Safaei H. Detection of Helicobacter pylori in city water, dental units′water, and bottled mineral water in Osfahan Iran[J]. Scientific World J, 2013,2013:280510.
|
27 |
Perez LM, Codony F, Lopez Leyton D, et al. Quantification of Helicobacter pylori levels in soil samples from public playgrounds in Spain[J]. J Zhejiang Univ Sci B, 2010,11(1):27-29.
|
28 |
刘云达,高安宁,唐国都,等. 气温、气压、湿度的变化对消化性溃疡发病影响的研究[J]. 临床消化病, 2009,21(1):3-7.
|
29 |
Sánchez-Zauco N, Torres J, Gómez A, et al. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study[J]. BMC Cancer, 2017,17(1):384.
|
30 |
Akazawa Y, Fukuda D, Fukuda Y. Vonoprazan-based therpy for helicobacter pylori eradication: experience and clinical evidence[J]. Therap Adv Gastroenterol, 2016,9(6):845-852.
|
31 |
Kuipers EJ. Editorial: proton pump inhibitors, Helicobacter pylori and gastric cancer-the need for long-term follow-up[J]. Aliment Phamarmacol Ther, 2016,43(5):647-648.
|
32 |
Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study[J]. Gastroenterology, 2009,136(4):1234-1241.
|
33 |
Nozaki K, Shimizu N, Inada K, et al. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils[J]. Jpn J Cancer Res, 2002,93(10):1083-1089.
|
34 |
Yakoob J, Abbas Z, Khan R, et al. Anti-Helicobacter pylori activity and inhibition of Helicobacter pylori-induced release of IL-8 in AGS cells by plant extracts[J]. J Med Plant Res, 2013,7(15):970-979.
|
35 |
Muhammad JS, Zaidi SF, Shaharyar S, et al. Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation[J]. Biol Pharm Bull, 2015,38(1):109-115.
|
36 |
Butenko T, Jeverica S, Orel R, et al. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children[J/OL]. Helicobacter, 2017[Epub ahead of print].
|
37 |
Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children[J]. J Pediatr Gastroenterol Nutr, 2011,53(2):230-243.
|
38 |
Yang HR, Choi HS, Paik JH, et al. Endoscopic and histologic analysis of gastric mucosa-associated lymphoid tissue in children with Helicobacter pylori infection[J]. J Pediatr Gastroenterol Nutr, 2013,57(3):298-304.
|
39 |
Miyamoto M, Haruma K. Gastric ulcer and duodenal ulcer[J]. Nihon Rinsho, 2013,71(8):1418-1423.
|
40 |
da Silva-Etto JMK, Mattar R, Villares-Lopes CA, et al. Evaluation of diagnostic accuracy of two rapid stool antigen tests using an immunochromatographic assay to detect Helicobacter pylori[J]. Clin Biochem, 2017[Epub ahead of print]
|
41 |
Schoep TD, Fulurija A, Good F, et al. Surface properties of Helicobacter pylori urease complex are essential for persistence[J]. PLoS One, 2010,5(11):e15042.
|
42 |
Campanale M, Nucera E, Ojetti V, et al. Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study[J]. Dig Dis Sci, 2014,59(8):1851-1855.
|
43 |
Strugatsky D, McNulty R, Munson K, et al. Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori[J]. Nature, 2013,493(7431):255-258.
|
44 |
Su J, Zhou X, Chen H, et al. Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial[J]. Medicine (Baltimore), 2017,96(7):e5859.
|
45 |
Zhu XY, Liu F. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy[J]. J Dig Dis, 2017,18(4):195-202.
|
46 |
王献献,刘维明. 中医药治疗幽门螺杆菌感染相关胃病研究进展[J]. 云南中医药杂志, 2016,37(9):84-85.
|
47 |
周克伦,于征. 左金汤联合三联疗法治疗幽门螺杆菌阳性十二指肠球部溃疡的疗效观察[J]. 中医临床研究, 2015,7(10):74-75.
|
48 |
Xue J, Bai Y, Chen Y, et al. Expression of Helicobacter pylori AlpA protein and its immunogenicity[J]. World J Gastroenterol, 2005,11(15):2260-2263.
|
49 |
Bai Y, Zhang YL, Chen Y, et al. Cloning and expression and immunogenicity of Helicobacter pylori BabA2 gene[J]. World J Gastroenterol, 2004,10(17):2560-2562.
|
50 |
Landarani Z, Falsafi T, Mahboubi M, et al. Immunological detection of 34 KDa outer membrane protein as a functional form of OipA in clinical isolates of Helicobacter pylori[J]. Iran J Microbiol, 2014,6(5):324-329.
|
51 |
Gomez-Duarte OG, Lucas B, Yan ZX, et al. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B[J]. Vaccine, 1998,16(5):460-471.
|
52 |
Chen J, Lin M, Li N, et al. Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice[J]. Vaccine, 2012,30(36):5310-5315.
|
53 |
Todoroki I, Joh T, Watanae K, et al. Suppressive effects of DNA vaccine encoding heat shock protein on Helicobacter pylori-induced gastritis in mice[J]. Biochem Biophys Res Commun, 2000,277(1):159-163.
|
54 |
Miyashita M, Joh T, Watanabe K, et al. Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase[J]. Vaccine, 2002,20(17-18):2336-2342.
|
55 |
Mirzaei N, Poursina F, Moghim S, et al. The study of H. pylori putative candidate factors for single- and multi-component vaccine development[J]. Crit Rev Microbiol, 2017,43(5):631-650.
|